
    
      It is a prospective study and randomized performed in patients admitted to the emergency
      departement for acute exacerbation of COPD. The patients were divided in two groups: Group
      Terbutaline/Ipratropium Bromide; received Terbutaline + Ipratropium bromide in nebulization
      and Group Terbutaline received Terbutaline alone in nebulization)
    
  